Moving up:
Market News and Data brought to you by Benzinga APIs- Prothena Corp PRTA - up 24% - Reported clinical data to be presented at International Symposium on Amyloidosis. Morgan Stanley raised the price target on the stock from $35.00 to $53.00.
- First Solar FSLR - up 20% - Sees FY2014 EPS $2.20-2.60; sees sales $3.70B-4.0B. Sees FY2015 EPS $4.50-6.00; sees sales $3.80B-4.30B.
- Inovio INO - up 10.5% - Reports Q4 EPS of $(0.07) vs $(0.03) est; revenue of $1.70M vs $1.36M est.
- Horizon Pharma HZNP - up 10% - announced its plans to acquire privately held Vidara Therapeutics International for around $660 million.
- Vera Bradley VRA - up 7% - Reports Q4 EPS of $0.48 vs $0.46 est; revenue of $157.50M vs $146.86M est. Sees Q1 sales $116.0M-120.0M vs $123.10M est.
- KB Home KBH - up 6.8% - Reports Q1 EPS of $0.12 vs $0.08 Est; revenue of $450.70M vs $431.49M est.
- Synchronoss Technologies SNCR - up 5.9% - Wells Fargo released some bullish comments and feels confident in revenue outlook of cloud business.
- Central European Media Enterprises CETV - down 13% - Investors taking profits after the stock gained 6.9% on Tuesday.
- Kandi Technologies KNDI - down 10% - Raised $11 million in a private placement with two institutional investors for 606,000 shares valued at $18.24 per share. The company also issued 90,900 warrants struck at $22.80 per share which expires in 18 months.
- TheraputicsMD TXMD - down 9.6% - Announced the launch of an underwritten secondary public offering of 9,000,000 shares of its common stock.
- Orbitz OWW - down 9.2% - from Neutral to Sell and set the price target to $8.
- Castlight Health CSLT - down 8.2% - After gaining 155 percent on Friday, the first day of trading for the stock, investors continue to take profit.
- Manhattan Associates MANH - down 7.6% - Alimerka selected components from Manhattan's Supply Chain Commerce Solutions. The stock is giving back a fraction of its monster gains from the past 5 years.
- Geophysical Corporation IO - down 6% - Downgraded by Barclays from Overweight to Equalweight and lowered the price target from $5 to $4.
- Nu Skin NUS - down 5.6% - Temporarily suspending some promotional meetings in China.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
